Blog Post

Home > BHI News > Brian Mehling, M.D. – the Founder and Chief Medical Officer of Blue Horizon International (BHI), answers questions on Stem Cells in Regenerative Medicine

Brian Mehling, M.D. – the Founder and Chief Medical Officer of Blue Horizon International (BHI), answers questions on Stem Cells in Regenerative Medicine

by bluehorizon June 25, 2020

BHI News

22 / 35

Chinese doctor claims he made a breakthrough in coronavirus pandemic with stem cell injections – having 100% success rate after treating nine mostly elderly patients

BHI News

Brian Mehling, MD of Mehling Orthopedics Named NJ Top Doc For 2023

BHI News

BHI THERAPEUTIC SCIENCES SCIENTIFIC ADVISORY BOARD CHAIRMAN RECEIVES APPROVAL TO USE STEM CELL PRODUCT IN CLINICAL TRIALS

BHI News

Social Media

About Us

BHI Rejuve is a hormone optimization program where each patient is evaluated with an extensive assessment of labs. After all labs are completed by the patient, a comprehensive evaluation of the results is conducted; if necessary, patients are put on a hormone optimization program which is personalized for each individual.

Find Us

Long Island Location:
800 Montauk Highway, West Islip, NY, 11795
Phone Number: 1-855-553-8500

NYC Location:
330 E 38th Street, PH57jk, New York, NY, 10016

Hackensack Location:
214 State St, Suite 101 Hackensack, NJ 07601

Blog Post

Brian Mehling, M.D. – the Founder and Chief Medical Officer of Blue Horizon International (BHI), answers questions on Stem Cells in Regenerative Medicine

Related Posts

Chinese doctor claims he made a breakthrough in coronavirus pandemic with stem cell injections – having 100% success rate after treating nine mostly elderly patients

Brian Mehling, MD of Mehling Orthopedics Named NJ Top Doc For 2023

BHI THERAPEUTIC SCIENCES SCIENTIFIC ADVISORY BOARD CHAIRMAN RECEIVES APPROVAL TO USE STEM CELL PRODUCT IN CLINICAL TRIALS

Categories

Social Media